Defective B cell development and function in Btk-deficient mice

Overview of attention for article published in Immunity, September 1995

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

policy: 1 policy source
patent: 77 patents

wikipedia: 2 Wikipedia pages

Readers on

mendeley: 163 Mendeley

So far, Altmetric has seen 77 patents that reference this research output.

Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)

Grant US-12415803-B2

United States of America

16 Sep 2025

PRIMARY CARBOXAMIDES AS BTK INHIBITORS

Application EP-4008328-A1

European Patent Office

08 Jun 2022

Heteroaryl compounds as BTK inhibitors and uses thereof

Grant US-11098041-B2

United States of America

24 Aug 2021

Btk knock-out pig Models and the uses thereof

Grant KR-102270145-B1

Republic of Korea

01 Jul 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 73 additional patents.